Welcome to HANA Pharm.¡¯s Homepage  
 
 
HOME > R&D > R&D Project
 

Active Ingredient

Commercial Name

Status

Amlodipine maleate

Novacot Tab.

end item marketing after materials synthesizing

Aceclofenac

Cenital Tab.

end item marketing after materials synthesizing

Alibendol

Alione Tab.

end item marketing after materials synthesizing

Atracurium besylate

Atra Inj. 2.5ml

end item marketing after materials synthesizing

Cimetropium bromide

Alpit Inj.

end item marketing after materials synthesizing

Carvedilol

Cavetrend Tab.

end item marketing after materials synthesizing

Dexibuprofen

Dexafen Tab.

end item marketing after materials synthesizing

Felodipine

Stapin ER Tab.

end item marketing after materials synthesizing,

Finasteride

Procare Tab.

end item marketing after materials synthesizing

fentanyl

Fentas Patch

end item marketing after developing patch product

Flecainide Acetetate

Fulcard Tab. 50mg

end item marketing after materials synthesizing

Glimepiride

Dairid Tab.

end item marketing after materials synthesizing

Gabapentine

New-gaba Cap.

end item marketing after materials synthesizing

Ketorolac tromethamine

Keromin Inj.

end item marketing after materials synthesizing

Loxoprofen sodium

Luckyfen Tab.

end item marketing after materials synthesizing

Levosulpiride

Levomin Tab.

end item marketing after materials synthesizing

Meloxicam

Memobic Cap.

end item marketing after materials synthesizing

Ondansetron HCl

Hana Ondansetron Tab.

end item marketing after materials synthesizing

Phendimetrazine¤ýL-tartarte

Fenslim Tab.

end item marketing after materials synthesizing

Propopol 

Anepol

end item marketing after developing emulsion

Simvastatine

Simcol Tab.

end item marketing after materials synthesizing

Tiropramide HCl

Tipas Tab.

end item marketing after materials synthesizing

Triflusal

Tigrin Cap.

end item marketing after materials synthesizing

Warfarine sodium

Kufarin Tab.

end item marketing after materials synthesizing